To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Kennedy Jr., who was tapped to lead the Department of Health and Human Services for the Trump administration, recently ...

With GLP-1 weight loss comes muscle loss. Gyms and personal trainers are rising to the challenge to help people build it back ...

The company wants to create two focused companies dedicated to driving current and future value in their respective ...

CordenPharma, a CDMO focused on peptides and peptide-based therapeutics, announced a partnership with Viking Therapeutics. The two companies will work together to ensure the production of Viking’s GLP ...

The deal gives the Swiss pharma access to an experimental amylin-targeting treatment it will test in combination with drugs ...

I’m trying to lose the 18 pounds I have gained since the pandemic. It has been hard enough that I’m wondering about Ozempic. How does that work? I’m ...

Because obesity and obesity-related conditions have been linked to several types of cancer, doctors believe that these ...

FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...

Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US ...

Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...